MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$3,738,821
Revenues
$2,045,133
Operating loss
-$3,330,871
Total other (expense)
income
-$407,950
Gross profit
$604,541
Interest income
$21,399
Change in fair value of
derivative liabilities
$7,737
Cost of revenues
$1,440,592
Total operating
expenses
$3,935,412
Loss on issuance of
convertible note
-$280,764
Interest expense
$156,207
Other (expense)
income, net
-$115
Sales, general and
administrative
$3,342,843
Research and development
$592,569
Back
Back
Income Statement
source: myfinsight.com
20 20 Biolabs, Inc. (AIDX)
20 20 Biolabs, Inc. (AIDX)